Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric acid oxide

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 2, 1997, Pages 521-527

  Itzhak, Yossef ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 NITROINDAZOLE; COCAINE; METHAMPHETAMINE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR MODIFICATION; CONTROLLED STUDY; CROSS ALLERGY; DRUG ABUSE; DRUG SENSITIVITY; ENZYME INHIBITION; INHIBITION KINETICS; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY;

ANIMALS; BRAIN; COCAINE; CONDITIONING, CLASSICAL; ENZYME INHIBITORS; INDAZOLES; MALE; METHAMPHETAMINE; MICE; MOTOR ACTIVITY; NITRIC OXIDE SYNTHASE;

EID: 0030791540     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. ABEKAWA, T., OHMORI, T. AND KOYAMA, T.: Effects of nitric oxide (NO) synthesis inhibition on the development of supersensitivity to stereotypy and locomotion stimulating effects of methamphetamine. Brain Res. 679: 200-204, 1995.
2. BOWYER, J. F., CLAUSING, P., GOUGH, B., SLIKKER, W. JR., HOLSON, R. R.: Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/ putamen. Brain Res. 699: 62-70, 1995.
3. CARLSSON, M. AND CARLSSON, A.: Interactions between glutamatergic and monoaminergic systems within the basal ganglia: Implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13: 272-276, 1990.
4. CHAUDHRY, I. A., TURKANIS, S. A. AND KARLER, R.: Characterization of "reverse tolerance" to amphetamine-induced locomotor stimulation in mice. Neuropharmacology 27: 777-781, 1988.
5. CROMBAG, H. S., BADIANI, A. AND ROBINSON, T. E.: Signalled and un-signalled intravenous amphetamine: large differences in the acute psychomotor response and sensitization. Brain Res. 722: 227-231, 1996.
6. GARTHWAITE, J.: Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14: 60-67, 1991.
7. G-Nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release. J. Pharmacol. Exp. Ther. 277: 1424-1430, 1996.
8. ITZHAK, Y.: Nitric oxide (NO) synthase inhibitors abolish cocaine-induced toxicity in mice. Neuropharmacology 32: 1069-1070, 1993.
9. ITZHAK Y.: Blockade of sensitization to the toxic effects of cocaine in mice by nitric oxide synthase inhibitors. Pharmacol. Toxicol. 74: 162-166, 1994.
10. ITZHAK, Y.: Attenuation of cocaine kindling by 7-nitroindazole, an inhibitor of brain nitric oxide synthase. Neuropharmacology 35: 1065-1073, 1996.
11. ITZHAK, Y. AND ALI, S. F.: The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J. Neurochem. 67: 1770-1773, 1996.
12. ITZHAK, Y. AND STEIN, I.: Sensitization to the toxic effects of cocaine in mice is associated with the regulation of N-methyl-D-aspartate (NMDA) receptors in the cortex. J. Pharmacol. Exp. Ther. 262: 464-470, 1992.
13. KALIVAS, P. W. AND STEWART, J.: Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res. Rev. 16: 223-244, 1991.
14. KARLER, R., CALDER, L. D. AND BEDINGFIELD, J. B.: Cocaine behavioral sensitization and excitatory amino acids. Psychopharmacology 115: 305-310, 1994.
15. KARLER, R., CALDER, L. D., CHAUDHRY, I. A. AND TURKANIS, S. A.: Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci. 45: 599-606, 1989.
16. KARLER, R., CHAUDHRY, I. A., CALDER, L. D. AND TURKANIS, S. A.: Amphetamine behavioral sensitization and excitatory amino acids. Brain Res. 537: 76-82, 1990.
17. KIM, H-S. AND PARK, W.-K.: Nitric oxide mediation of cocaine-induced dopaminergic behaviors: ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice. J. Pharmacol. Exp. Ther. 275: 551-557, 1995.
18. 3H]dopamine release from striatal slices. J. Neurosci. Res. 35: 192-198, 1993.
19. MONTAGUE, P. R., GANCAYCO, C. D., WINN, M. J., MARCHASE, R. B. AND FRIEDLANDER, M. J.: Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 263: 973-977, 1994.
20. MOORE, P. K., BABBEDGE, R. C., WALLACE, P., GAFFEN, Z. A. AND HART, S. L.: 7-Nitroindazole, an inhibitor of nitric oxide synthase, exhibits antinociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108: 296-297, 1993.
21. NASH, J. F. AND YAMAMOTO, B. K.: Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methyleneddioxymethamphetamine. Brain Res. 581: 237-243, 1992.
22. OHNO, M. AND WATANABE, S.: Nitric oxide synthase inhibitors block behavioral sensitization to methamphetamine in mice. Eur. J. Pharmacol. 275: 39-44, 1995.
23. PIERCE, R. C., BELL, K., DUFFY, P. AND KALIVAS, P. W.: Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J. Neurosci. 16: 1550-1560, 1996.
24. POST, R. M., WEISS, S. R. AND PERT, A.: Cocaine-induced behavioral sensitization and kindling: Implications for the emergence of psychopathology and seizures. In The Mesocorticolimbic Dopamine System (Annals of the New York Academy of Science, vol. 537), ed. by P. W. Kalivas and C. B. Nemmeroff, pp. 292-308, The New York Academy of Science, New York, 1988.
25. PUDIAK, C. M. AND BOZARTH, M. A.: L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci. 53: 1517-1524, 1993.
26. PULVIRENTI, L., BERRIER, R., KREIFELDT, M. AND KOOB, G, F.: Modulation of locomotor activity by NMDA receptors in the nucleus accumbens core and shell regions. Brain Res. 664: 231-236, 1994.
27. ROBINSON, T. E. AND BECKER, J. B.: Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11: 157-198, 1986.
28. ROBINSON, T. E. AND BERRIDGE, K. C.: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18: 247-291, 1993.
29. ROBINSON, T. E., JURSON, P. A., BENNETT, J. A. AND BENTGEN, K. M.: Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 462: 211-222, 1988.
30. SHIBATA, M., ARAKI, N., OHTA, K., HAMADA, J., SHIMAZU, K. AND FUKUUCHI, Y.: Nitric oxide regulates NMDA-induced dopamine release in the striatum. NeuroReport 7: 605-608, 1996.
31. SILVA, M. T., ROSE, S., HINDMARSH J. G., AISLAINTER, G., GORROD, J. W., MOORE, P. K., JENNER, P. AND MARSDEN, C. D.: Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by novel monosodium salt of 7-nitroindazole. Br. J. Pharmacol. 114: 257-258, 1995.
32. SMITH, J. A., Mo, Q., Guo, H., KUNKO, P. M. AND ROBINSON, S. E.: Cocaine increases extraneuronal levels of aspartate and glutamate in the nucleus accumbens. Brain Res. 683: 264-269, 1995.
33. SNYDER, S. H.: Nitric Oxide: first in a new class of neurotransmitter? Science 257: 494-496, 1992.
34. STEWART, J., DESCHAMPS, S.-E. AND AMIR, S.: Inhibition of nitric oxide synthase does not block the development of sensitization to the behavioral activating effects of amphetamine. Brain Res. 641: 141-144, 1994.
35. STEWART, J, AND VEZINA, P.: Conditioning and behavioral sensitization. In Sensitization in the Nervous System, ed. by P. W. Kalivas and N. J. Barnnes, pp. 207-224, Telford Press, Caldwell, NJ, 1988.
36. STRASSER, A., MCCARRON, R. M., ISHII, H., STANIMIROVIC, D. AND SPATZ, M.: L-Arginine induces dopamine release from striatum in vivo. NeuroReport 5: 2298-2300, 1994.
37. WEISS, F., PAULUS, M. P., LORANG, M. T. AND KOOB, G. F.: Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: Effects of acute and repeated administration. J. Neurosci. 112: 4372-4380, 1992.
38. WOLF, M. E. AND JEZIORSKI, M.: Co-administration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res. 613: 291-294, 1993.
39. WOLF, M. E., XUE, C-J., WHITE, F. J. AND DAHLIN, S. L.: MK-801 does not prevent acute stimulatory effects of amphetamine and cocaine on locomotor activity or extracellular dopamine levels in the nucleus accumbens. Brain Res. 666: 223-231, 1994.
40. ZHU, X.-Z. AND Luo, L.-G.: Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J. Neurochem. 59: 932-935, 1992.